Laryngeal Blastomycosis, an Unexpected Diagnosis: A Case Report

Published:October 05, 2020DOI:


      Isolated laryngeal blastomycosis is an extremely rare entity with few cases described in the medical literature. Nonspecific and chronic presenting symptoms such as dysphonia, dyspnea, dysphagia, and/or cough are described, with isolated reports requiring urgent management related to respiratory distress. We present a case report of a 63-year-old immunocompetent female diagnosed with isolated laryngeal blastomycosis, document the treatment regimen and subsequent clinical course. In view of the rarity of this diagnosis, isolated laryngeal blastomycosis has the potential for clinical and pathologic misdiagnosis. Without an accurate diagnosis, blastomycosis remains untreated and the risk for airway disease progression increases.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Voice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bariola JR
        • Hage CA
        • Durkin M
        • et al.
        Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis.
        Diagn Microbiol Infect Dis. 2011; 69: 187-191
        • Bradsher RW.
        • Chapman SW.
        • Pappas PG.
        Infect Dis Clin North Am. 2003; 17 (vii): 21-40
        • Cates DJ.
        • Rosen CA.
        • Yassin MH.
        • et al.
        Primary laryngeal blastomycosis: diagnostic challenges and advances in a rare cause of laryngitis.
        Laryngoscope. 2019; 129: 2531-2533
        • Chapman SW
        • Dismukes WE
        • Proia LA
        • et al.
        Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America.
        Clin Infect Dis. 2008; 46: 1801-1812
        • Chapman SW
        • Lin AC
        • Hendricks KA
        • et al.
        Endemic blastomycosis in Mississippi: epidemiological and clinical studies.
        Semin Respir Infect. 1997; 12 (Available at:): 219-228
        • Ebeo CT
        • Olive K
        • Byrd Jr., RP
        • et al.
        Blastomycosis of the vocal folds with life-threatening upper airway obstruction: a case report.
        Ear Nose Throat J. 2002; 81 (Available at:): 852-855
        • Frost HM
        • Novicki TJ
        Blastomyces antigen detection for diagnosis and management of blastomycosis.
        J Clin Microbiol. 2015; 53: 3660-3662
        • Martynowicz MA
        • Prakash UB
        Pulmonary blastomycosis: an appraisal of diagnostic techniques.
        Chest. 2002; 121: 768-773
        • McBride JA
        • Gauthier GM
        • Klein BS
        Clinical manifestations and treatment of blastomycosis.
        Clin Chest Med. 2017; 38: 435-449
        • Pappas PG
        Blastomycosis in the immunocompromised patient.
        Semin Respir Infect. 1997; 12 (Available at:): 243-251
        • Richer SM
        • Smedema ML
        • Durkin MM
        • et al.
        Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1.
        Clin Vaccine Immunol. 2014; 21: 143-146
        • Rucci J
        • Eisinger G
        • Miranda-Gomez G
        • et al.
        Blastomycosis of the head and neck.
        Am J Otolaryngol. 2014; 35: 390-395
        • Saccente M
        • Woods GL
        Clinical and laboratory update on blastomycosis.
        Clin Microbiol Rev. 2010; 23: 367-381
        • Smith JA
        • Gauthier G
        New developments in blastomycosis.
        Semin Respir Crit Care Med. 2015; 36: 715-728